Prostate cancer detection: The value of performing an mri before a biopsy

Acta Radiologica

Volumn 50, Issue 9, 2009, Pages 1080-1088

  Shimizu, T ^a   Nishie, A ^b   Ro, T ^c   Tajima, T ^b   Yamaguchi, A ^c   Kono, S ^c   Honda, H ^b  

^a Saga Prefectural Hospital   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c HARASANSHIN HOSPITAL   (Japan)

Author keywords

Apparent diffusion coefficient map; Biopsy; Diffusion weighted imaging; MRI; Prostate cancer

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; APPARENT DIFFUSION COEFFICIENT MAP; DETECTABILITY; DIFFUSION-WEIGHTED IMAGING; GLEASON SCORES; GOLD STANDARDS; MRI; MRI SEQUENCES; POSITIVE PREDICTIVE VALUES; PROSTATE CANCER; PROSTATE CANCER DETECTION; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; T2-WEIGHTED IMAGING; TRANSITION ZONES; TRANSRECTAL ULTRASONOGRAPHY; TUMOR SIZE; WHOLE-MOUNT SECTIONS;

MAGNETIC RESONANCE IMAGING; MULTICARRIER MODULATION; PEELING; SURFACE DIFFUSION; TUMORS; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

BIOPSY;

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BIOPSY; BLOOD; CHI SQUARE DISTRIBUTION; ECHOGRAPHY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; BIOPSY; CHI-SQUARE DISTRIBUTION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 70449098938     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.3109/02841850903216718     Document Type: Article

References (19)

1. Aus G, Bergdahl S, Lodding P, Lilja H, Hugosson J. Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer*results from a prospective, population-based randomized controlled trial. Eur Urol 2007;/51:/659-64.
2. Oberaigner W, Horninger W, Klocker H, Schö nitzer D, Stü hlinger W, Bartsch G. Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate- speci.c antigen testing. Am J Epidemiol 2006;/164:/ 376-84.
3. Loch T, Eppelmann U, Lehmann J, Wullich B, Loch A, Stö ckle M. Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sonomorphologically suspicious lesions. World J Urol 2004;/ 22:/357-60.
4. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step-section histology. J Urol 2000;/164:/400-4. (Pubitemid 30481935)
5. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;/243:/28-53.
6. Haider MA, Kwast TH, Tanguay J, Evans AJ, Hashimi A-T, Lockwood G, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. Am J Roentgenol 2007;/189:/323-8.
7. Morgan VA, Kyriazi S, Ashley SE, deSouza NM. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol 2007;/48:/ 695-703.
8. Shimofusa R, Fujimoto H, Akamata H, Motoori K, Yamamoto S, Ueda T, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005;/29:/ 149-53.
9. deSouza NM, Reinsberg SA, Scurr ED, Brewster JM, Payne GS. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coef.cients for identifying malignant nodules. Br J Radiol 2007;/80:/ 90-5.
10. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007;/25:/146-52.
11. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis*correlation with biopsy and histopathology. J Magn Reson Imaging 2006;/24:/108-13.
12. Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, et al. Combined use of diffusionweighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. Am J Roentgenol 2007;/188:/91-8.
13. Costouros NG, Coakley FV, Westphalen AC, Qayyum A, Yeh BM, Joe BN, et al. Diagnosis of prostate cancer in patients with an elevated prostate-speci.c antigen level: role of endorectal MRI and MR spectroscopic imaging. Am J Roentgenol 2007;/188:/812-6.
14. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, et al. Prostate Ucancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;/195:/385-90.
15. Jager GJ, Ruijter ET, van de Kaa CA, de la Rosette JJ, Oosterhof GO, Thornbury JR, et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. Am J Roentgenol 1996;/166:/ 845-52.
16. Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR Imaging. Radiology 2006;/239:/784-92.
17. Allen KS, Kressel HY, Arger PH, Pollack HM. Agerelated changes of the prostate: evaluation by MR imaging. Am J Roentgenol 1989;/152:/77-81.
18. Mulkern RV, Barnes AS, Haker SJ, Hung YP, Rybicki FJ, Maier SE, et al. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 2006;/24:/ 563-8.
19. Nakashima J, Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K, et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004;/64:/101-5.